Download PDF

Other users also viewed these articles

Continuous intestinal infusion of levodopa¿carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous community D. Santos-García; M.J. Catalán; V. Puente; F. Valldeoriola; I. Regidor; P. Mir; J. Matías-Arbelo; J.C. Parra; F. Grandas;
Neurologia. 2021;36:101-11
Beta-caryophyllene inhibits the permeability of the blood¿brain barrier in MPTP-induced parkinsonism A.R. Ramos-Molina; A.R. Tejeda-Martínez; J.M. Viveros-Paredes; V. Chaparro-Huerta; M.F. Urmeneta-Ortíz; L.J. Ramírez-Jirano; M.E. Flores-Soto;
Neurologia. 2025;40:191-203
Dopamine agonist therapy in Parkinson¿s disease: Spanish expert consensus on its use in different clinical situations D. Santos García; J. Pagonabarraga Mora; F. Escamilla Sevilla; P.J. García Ruiz; J. Infante Ceberio; J. Kulisevsky Bojarski; G. Linazasoro Cristóbal; M.R. Luquín Piudo; J.C. Martínez Castrillo; S. Jesús Maestre; L. Vela Desojo; F.J. Campos Lucas; F. Caballero Martínez; P. Mir;
Neurologia. 2025;40:171-81